Gossamer Bio(GOSS.US)

Last Updated 19:00:00 ET
longbridge loading

U.S. stock market movement update: Cava rises 7.27% leading the rebound, Jianzhi Edu Tech falls 8.19% under pressure

Price Alert·
US
JZ
-7.00%
US
CAVA
-2.22%
US
GOSS
+3.32%
Price Alert·
US
JZ
-7.00%
US
CAVA
-2.22%
US
GOSS
+3.32%

U.S. stock night trading volatility: Gossamer Bio rose 5.19% in after-hours trading, boosted by dual positive factors of debt restructuring and successful trials enhancing market confidence

Price Alert·
US
GOSS
+3.32%
Price Alert·
US
GOSS
+3.32%

GOSS 2-WEEK DEADLINE ALERT: Gossamer Bio Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Placebo Risk: HBSS

PR Newswire·
US
GOSS
+3.32%
US
BBH
+0.68%
US
XBI
-0.69%
PR Newswire·
US
GOSS
+3.32%
US
BBH
+0.68%
US
XBI
-0.69%

Gossamer Bio Reports Q1 2026 Results: Full Earnings Call Transcript

benzinga_article·
US
GOSS
+3.32%
US
XBI
-0.69%
US
SBIO
-1.24%
benzinga_article·
US
GOSS
+3.32%
US
XBI
-0.69%
US
SBIO
-1.24%

Here are the major earnings after the close Monday

MSN·
US
GOSS
+3.32%
US
AGYS
+12.45%
US
MUFG
+1.35%
MSN·
US
GOSS
+3.32%
US
AGYS
+12.45%
US
MUFG
+1.35%

12 Health Care Stocks Moving In Monday's Pre-Market Session

benzinga_article·
US
GOSS
+3.32%
US
LTRN
+3.00%
US
AIM
+0.74%
benzinga_article·
US
GOSS
+3.32%
US
LTRN
+3.00%
US
AIM
+0.74%

Gossamer Bio Restructures Debt and Advances Seralutinib Program

Tip Ranks·
US
GOSS
+3.32%
US
SBIO
-1.24%
US
IHE
+1.26%
Tip Ranks·
US
GOSS
+3.32%
US
SBIO
-1.24%
US
IHE
+1.26%
© 2026 Longbridge｜Disclaimer